Author

Zahra Rikhtegaran Tehrani

National Institutes of HealthORCID 0000-0002-1127-1290Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:genetic perturbation / CRISPR· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Alicia SatoiD· 2 shared David C. MontefioriiD· 2 shared Michael S. SeamaniD· 2 shared Abdolrahim Abbasi· 1 shared Agnes M. Harskamp· 1 shared Aimee A. DesrosiersiD· 1 shared Albert CupoiD· 1 shared Alex C. Sullivan· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alicia SatoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 26, 2026

Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans

Tom G. Caniels, Madhu S. Prabhakaran, Sashank Agrawal…·Rogier W. Sanders

This study shows that sequential vaccination can mature VRC01-class B cells into antibodies that neutralize a broad range of HIV-1 viruses.

DOI 10.64898/2026.10.21.760679

humanproteomics

BioengineeringStructurePeer-reviewedMay 14, 2025

A Comprehensive Engineering Strategy Improves Potency and Manufacturability of a Near Pan-neutralizing Antibody Against HIV

Mohammad M. Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani…·Anthony L. DeVico

This study engineers an HIV broadly neutralizing antibody to improve its potency, antiviral activity, and manufacturability while maintaining safety and efficacy.

11 citationstop 4%

humanproteomics